Morgan Stanley (NYSE:MS) has been analyzed by 12 analysts in the last three months, showing a mix of bullish to bearish sentiments. The average 12-month price target is now $92.43, down 7.46% from the previous $99.88. Analysts have made various rating changes and price target adjustments, with some raising and others lowering their expectations. Morgan Stanley's financial performance includes a market capitalization above industry average, a 2.3% revenue growth rate, a high net margin of 18.22%, and an ROE of 2.48%, but a lower-than-average ROA of 0.19% and a high debt-to-equity ratio of 2.84.